Middleton, G., Palmer, D. H., Greenhalf, W., Ghaneh, P., Jackson, R., Cox, T., Evans, A., Shaw, V. E., Wadsley, J., Valle, J. W., Propper, D., Wasan, H., Falk, S., Cunningham, D., Coxon, F., Ross, P., Madhusudan, S., Wadd, N., Corrie, P., Hickish, T., Costello, E., Campbell, F., Rawcliffe, C., & Neoptolemos, J. P. (n.d.). vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial. Lancet oncology, 18(4), 486–499. http://access.bl.uk/ark:/81055/vdc_100045252066.0x000017